Most people won't need a COVID-19 vaccine booster shot for years, vaccination experts predict
The U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices is meeting next week to discuss whether immunocompromised Americans should be authorized to receive a third dose of COVID-19 vaccine, and Pfizer said last week it will seek regulatory approval for an eventual third booster shot of its vaccine amid the rapidly spreading Delta variant. Israel said this week it will begin administering a third Pfizer dose to severely immunocompromised adults, and Britain has announced a plan to administer booster shots beginning in September.
The rapid spread of the Delta mutation among unvaccinated pockets of the U.S. combined with Pfizer's announcement "has unleashed third-dose panic among the vaccinated," Politico reports. But global public health officials are outraged that vaccine-rich countries would consider third shots before health care workers in many countries have gotten their first dose of a COVID-19 vaccine. And most U.S. public health and government officials say people won't need a booster shot now or anytime soon.
"There's no evidence right now that the general population needs a booster dose because we're not seeing evidence of waning immunity or substantially reduced effectiveness against the Delta variant," William Moss, executive director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health, tells Politico. "I think for most people, outside those special populations, the immunocompromised and maybe the elderly — I think most people's immunity is going to last years, to be honest." He said if a variant manages to evade the vaccines, a booster shot may be needed, but he guessed it will be three or four years, or longer, before most people need an extra dose.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"I haven't seen evidence that a booster would be indicated for anybody, including the immunocompromised," Helen Boucher, an infectious-disease doctor at Tufts Medical Center in Boston, tells The Washington Post. She said the best way to protect immunocompromised people is to make sure everyone around them is vaccinated.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
What is Roomba’s legacy after bankruptcy?In the Spotlight Tariffs and cheaper rivals have displaced the innovative robot company
-
SiriusXM hopes a new Howard Stern deal can turn its fortunes aroundThe Explainer The company has been steadily losing subscribers
-
Unemployment rate ticks up amid fall job lossesSpeed Read Data released by the Commerce Department indicates ‘one of the weakest American labor markets in years’
-
A fentanyl vaccine may be on the horizonUnder the radar Taking a serious jab at the opioid epidemic
-
Health: Will Kennedy dismantle U.S. immunization policy?Feature ‘America’s vaccine playbook is being rewritten by people who don’t believe in them’
-
How dangerous is the ‘K’ strain super-flu?The Explainer Surge in cases of new variant H3N2 flu in UK and around the world
-
Vaccine critic quietly named CDC’s No. 2 officialSpeed Read Dr. Ralph Abraham joins another prominent vaccine critic, HHS Secretary Robert F. Kennedy Jr.
-
This flu season could be worse than usualIn the spotlight A new subvariant is infecting several countries
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
